In order to evaluate cell-and disease-specific changes in the interacting strength of chromatin targets, ChIP-seq signal across multiple conditions must undergo robust normalization. However, this is not possible using the standard ChIP-seq scheme, which lacks a reference for the control of biological and experimental variabilities. While several studies have recently 20
BACKGROUND
Chromatin is the macromolecular complex of DNA and histone proteins that packs the genome into its basic structural units of nucleosomes [1] . Within chromatin, a plethora of interacting proteins organize the 3D distribution of the genome, regulate multiple gene expression 35 programs, and coordinate the appropriate transmission of genetic and epigenetic information to cellular progeny [1] [2] [3] [4] [5] . Alterations in the functionality of the proteins associated with chromatin are intimately linked to severe developmental diseases and cancer [6] . Indeed, one recent comprehensive analysis of 10,437 cancer exomes has revealed that nearly 40% of all cancer driver genes are well-characterized chromatin associated factors, which include transcription 40 factors, chromatin modifiers, chromatin remodelers, and guardians of genomic stability [7] . Due to its biological and pathological relevance, research on chromatin and epigenetics has been a rapidly moving field over the last decade, assisted by the development of novel methods for the high-throughput molecular analysis of the genome.
The development of chromatin immunoprecipitation (ChIP) coupled with the next-generation 45 sequencing (seq) methodologies has been pivotal for characterizing the genomic distribution of a vast collection of chromatin-associated proteins, histone post-translational modifications (PTMs), and histone variants [8] [9] [10] [11] . The striking impact of the ChIP-seq technology is based in its relative technical simplicity (which allows it to be adopted by most experimental laboratories), its sensitivity and accuracy for mapping the genomic distribution of proteins, and 50 the standardization of the experimental and computational methods to efficiently analyze such a volume of information. Fifteen years ago, the Encyclopedia of DNA Elements (ENCODE) project was launched as a collaborative initiative to catalog the complete set of functional elements in the human genome in selected cell lines [12, 13] . More recently, the International Human Epigenome Consortium (IHEC) has generated a comprehensive high-resolution 55 reference map for the epigenome of major primary human cell types [14, 15] . The ChIP-seq method has been central for building the cartography of functional elements of the human genome in both of these international collaborative efforts.
Current research efforts aim to identify the changes in the occupancy profiles of chromatinbound factors or histone modifications in two or more cell types, metabolic states, and/or 60 pathological situations. However, in its traditional scheme, ChIP-seq is essentially a semiquantitative method that enables the researcher to determine the relative occupancy of one factor in a given genomic region, with respect to the rest of the genome. In other words, there is no direct correlation between the amount of ChIP signal in the output and the biological activity of the binding element in different scenarios [16] . Several sources of biological and 65 technical variability can be overlooked, thereby hampering any direct comparison of ChIP signal strength between different conditions [17] . For instance, the method of preparation of the sequencing material by ChIP is a source of technical variability. An apparent increase in genomic occupancy of a chromatin factor could simply be the result of variability in the efficiency of immunoprecipitation or DNA elution between experiments. Moreover, while 70 running the sequencer, a standard practice is to mix equal proportions of barcoded libraries to run the samples in a multiplexed manner. Therefore, even a substantial global reduction of a histone variant occupancy per cell would remain hidden in a ChIP-seq experiment after normalizing by total number of reads [17] . Although the consistent replication of ChIP-seq experiments can reveal the biological tendency in the interacting strength of the chromatin 75 factor, a robust normalizing strategy is required to accurately compare ChIP-seq results across experimental conditions.
To overcome the influence of technical variabilities in the biological interpretation of ChIP-seq, several groups have reported different strategies based on the use of internal reference controls (spike-in), which provides a feasible solution to accurately normalize comparative 80
ChIP-seq (Table 1) . Originally developed to correct gene expression measurement in microarrays and RNA-seq experiments [18, 19] , the spike-in strategy is based on combining the experimental sample with an amount of exogenous material (either from another species or synthetically produced) that is constant between experiments. Both the experimental sample and the spike-in are processed and analyzed in parallel. As long as the amount of 85 spike-in ChIP signal is constant, the observable differences in the experimental samples across conditions can be exclusively attributed to biological variation. Eventual differences in the spike-in signal can be computationally equilibrated to eliminate technical variability, and the same correction is then used to normalized the experimental signal.
Current strategies for ChIP-seq normalization using spike-in diverge in: i) the type of biological 90 material to be used as a reference sample for normalization; ii) the capturing method of the spike-in material; and, iii) the computational method used to analyze the sequencing data. It is important to mention that the use of different strategies can introduce inconsistencies to the final results, as each method presents its own benefits and limitations. In addition, the existence of several alternatives might complicate decision-making for researchers about 95 when and how to apply a normalization method for comparative ChIP-seq. With the aim of providing a practical, unified reference framework for comparative ChIP-seq analysis, we have now evaluated the benefits and limitations of the experimental methodologies and analytical pipelines currently available. We have proposed an experimental best practice and, in addition, we have designed a companion bioinformatics pipeline for analyzing comparative ChIP-seq 100 data in a genome-wide manner. If widely used, we believe that this computational pipeline can serve as a reference for increasing data reproducibility between laboratories, thus overcoming one of the major drawbacks of using ChIP-seq data.
RESULTS AND DISCUSSION

Comparison of current experimental methodologies 105
Over the last five years, up to four alternative strategies have been proposed based on the spike-in concept to deal with the problem of a lack of comparability between multiple ChIP-seq samples. An additional normalization method has been also developed using nucleosomes reconstituted from recombinant and semisynthetic histones on barcoded DNA prior to immunoprecipitation (ICeChIP, Internal Standard Calibrated ChIP) [20] . Although considerably 110 useful for the accurate quantification of local histone modification densities, we have focused on protocols compatible with cross-linked ChIP-seq against any potential target of interest. We have summarized the principal benefits and limitations of each technique in Table 1 .
In 2014, two different laboratories independently pioneered the development of a similar strategy for comparative ChIP-seq normalization, by introducing xenogenic material from a 115 second different species into the experimental model [21, 22] . The rationale behind both approaches is that the ChIP-seq signal obtained from a fixed amount of spike-in material can be used as an internal reference to normalize the experimental ChIP signal across different samples. Thus, Guenther and collaborators mixed Drosophila melanogaster S2 cells with human cells before cell lysis [21] , while Delorenzi and colleagues added a constant amount of 120 fragmented chromatin from human cells into previously-fragmented mouse chromatin [22] .
Despite the conceptual similarities, the initial decision on which spike-in material should be added to the experimental sample raises important technical considerations that can influence the resulting biological interpretations. The addition of xenogenic cells of the spike-in material enables the whole procedure to be monitored from the beginning, thereby minimizing the 125 impact of technical variabilities for the biological interpretation. Further, by mixing cells, it is possible to tackle eventual changes in genomic ploidy (e.g. due to genomic instability, or differences in cell cycle progression), thereby providing an estimation of average ChIP-seq signal per cell. This quantitative estimation is not possible when mixing fragmented chromatin.
However, the option of mixing cells is only available when the number of cells can be evaluated 130 accurately (e.g. cells growing on a dish), or when the experimental sample and spike-in material are fragmented with the same settings. On the contrary, when number of cells in the sample is uncertain (e.g. animal tissue samples), or when the experimental sample and spikein material require different settings for fragmentation, the addition of the fragmented spike-in material at chromatin level is a more appropriate option. 135
In the previous strategies, the sample and the spike-in material are captured using the same antibody, limiting both strategies to using antigens that are highly conserved between both classes of material (for instance, histone modifications). To circumvent this problem, Trojer and colleagues introduced a smart solution by using a second antibody for a fly-specific histone variant (H2Av) to capture the spike-in material [23] . This strategy aims to avoid the cross-140 reactivity constraint of the experimental antibody and to reduce any potential variability due to competition between the spike-in control and the experimental material, which usually exceeds the amount of spike-in material by far.
In order to overcome both epitope conservation restrictions and the use of a xenogenic spike material, a fourth normalizing strategy has been recently proposed: rather than using 145 exogenous material, Guertin and co-workers recommend including a second antibody against an endogenous target present in the experimental chromatin, as an internal control [24] . This second antibody is used to profile the genomic occupancy of a pervasive chromatin factor (e.g. CTCF) whose genomic distribution is assumed to be unchanged between different cell types and/or treatments and which is clearly distinguishable from the experimental target [24] . 150
Nonetheless, although this method avoids preparation of xenogenic material, we consider that it still makes two important assumptions, which could not be always true: i) that the reference endogenous factor remains stably associated under different experimental conditions; and, ii) that the genomic distributions of endogenous reference target and the experimental target do not overlap. 155
Towards an experimental framework for comparative ChIP-seq experiments
Considering the benefits and limitations of the different strategies (reviewed in Table 1 ), we propose the addition of exogenous xenogenic fly cells, whenever possible, and the use of a second antibody against a fly-specific histone variant, as a best practice for comparative ChIPseq normalization for mammalian genomes. We recommend using fly material as the spike-in 160 because: 1) the genome sequence has been extensively assembled; 2) the fly chromatin has been largely characterized at epigenetic levels; 3) the evolutionary distance between fly and mammalian genomes is sufficient to allow an unambiguous alignment of the reads [21, 23] ; and 4) fly cells are relatively easy to culture with standard tissue culture procedures and instruments. Moreover, the genomic occupancy profile of the fly-specific H2Av is already 165 characterized [23] , which can be extremely useful as an additional control point for assessing ChIP-seq performance.
Taking into account the previous considerations, we have designed a practical guide under the form of a decision tree to systematically implement a consistent protocol for the addition of the spike-in material when performing ChIP-seq experiments. In our roadmap, we state some 170 key questions that are relevant for deciding which type of spike-in to add (e.g. fly cells or fragmented chromatin, see data flow diagram in Fig. 1 ). These guidelines take into consideration that: (i) spike-in material should be present in all samples at equal amounts at the earliest step during the ChIP-seq procedure; and (ii) spike-in material should be present in a low-enough quantity (giving a significantly lower number of reads as that of the experimental 175 reads) to not interfere with the actual ChIPseq experiment yet still give an accurate normalization in the final sequencing data. As previously reported, the number of spike-in reads in the final sequencing step should be at least one million reads, and approximately, 2%-5% of the experimental genome, to minimize the changes in overall material used for ChIP-seq [21, 23] . This final amount of reads can be influenced by the ratio of the mixture as 180 well as by the quality of the antibody and/or the abundance of the target in the experimental condition. Taking into account these considerations, and the relative ratio between the size of the fly genome and the two most widely used mammalian experimental models (mouse and human), we recommend the use of different final mixtures ( Fig. 1 ).
Comparison of current computational methodologies 185
Traditionally, the standard ChIP-seq normalization method uses the total number of mapped reads per million (RPM) to correct for possible bias introduced by the differences in the sequencing depth among samples. With the recent spike-in methods (see Table 1 ), the mapped reads from the spike-in control are employed to correct the experimental ChIP-seq signal strength. 190
At the computational level, the rationale of the different spike-in methodologies is the same:
as long as a constant amount of spike-in material is added to the experimental samples, and as long as the samples and the spike-in material are processed and analyzed together, the correction factor computed to eliminate the differences in the spike-in signal can be used to normalize the experimental sample signal. However, the different methodologies differ in the 195 computational approach to correct the spike-in and, consequently, the experimental sample.
Several authors have proposed to take advantage of the number of mapped reads of the spikein sample (e.g. Drosophila melanogaster) to correct the overall ChIP-seq signal from the main organism studied (e.g. human) [21, 23] . Although initially appealing, this fold-change correction presents in our opinion important shortcomings, such as: i) the spike-in reads mapped not only 200 along the ChIP-seq peaks but also over background regions are used for computing the correction factor; and ii) the correction factor is uniformly applied to all experimental reads in the actual experiment, treating both non-specific and specific signal loci with the same correction value. Alternatively, the use of a normalization factor computed derived from a predefined list of known targets in the spike-in organism was also proposed [22] . This option 205 excludes any confounding background signal, but the correction is only applied to a computational pre-defined loci list with specific ChIP-signal, thereby relying in the accuracy of the selected computational peak caller to define the list of positive loci.
Recently, with the aim of overcoming the limitations of the previous approaches, Guertin et al.
proposed to apply a linear local regression method [24] . This approach computes a correction 210 coefficient, defined by a linear regression model, for the systematic and gradual correction of the pre-defined ChIP-seq peaks from the reference. After this, the coefficient is also used to correct a pre-defined subset of peaks in the experimental sample. In addition, such a linear correction method implements a statistical approach to calculate the probability and strength of differentially bound loci. Guertin et al. (23) also showed an increased sensitivity (of about 215 10%) in the detection of differentially bound target loci as compared to the previous absolute fold-change correction. The conceptual improvements of this approach stem from the fact that the correction factor gradually increases along with the informative power (as number of reads) of the peaks. However, the addition of a computational step to pre-select the real signal loci in this strategy, similar to the non-linear correction method, could introduce an additional bias 220 step, as the consistency in the outcome of available peak calling tools is limited [25] . In addition, this analysis would impede the genome-wide evaluation of the signal-to-noise ratio, thereby limiting the informative power of the ChIP-seq.
Benchmarking a novel local regression method for comparative ChIP-seq in a genomewide manner 225
With the aim to enable a genome-wide comparative analysis of ChIP-seq experiments, we developed a novel computational method that performs the genome-wide normalization of ChIP-seq data adapting the spike-in control correction to the class of genomic region (Fig. 2) .
Our strategy overcome the limitations from the previous strategies, as: 1) it normalizes ChIPseq signal over the complete genome, and not just from a subset of selected regions; 2) in 230 order to compute the correction factor, the influence of the reads from background regions, although dominating over the total number of reads, is minimized; and, 3) the correction factor derived from the spike-in material is not uniformly applied over all the experimental ChIP signal, instead, it is increasingly and gradually applied from background to positive ChIP signal regions. Our approach, inspired by the spike-in-based RNA-seq quantification methods 235 described above [18, 19] , shares conceptual similarities with the recent linear local correction approach [24] and consists in the application of a local regression, in this case, over all the genome-wide bins determined along the chromosomes (see Methods). Thereby, our method is able to introduce a distinct correction factor to each bin in the genome, depending on its class. First, a local regression (LOESS) is computed from the bins in the spike-in genome in 240 order to accommodate the two ChIP-seq conditions compared into the same best-fit line. Next, the values from the real experiment (experimental reads) are corrected following the previous local normalization calculated using the spike-in bins (Fig. 2) . Under this approach, the adjustment on a region containing a true ChIP-seq signal is expected to be substantially higher than the change computed for bins with background signal. 245
To assess the accuracy of our proposal, we compared the performance of our LOESS method with the fold-change strategy on a reference dataset [21, 23] (Fig. 3 ). We took advantage of the available ChIP-seq data published by Guenther et al. that included fly material as spike-in control [21] . In this study, the authors artificially generated a pre-defined ChIP signal gradient for the di-methylation of lysine-79 histone H3 (H3K79me2). To achieve a controlled range of 250 distinct conditions, they mixed different proportions of Jurkat cells that had been untreated or treated with a selective inhibitor for the H3K79-methyltranferase DOT1L (EPZ5676). The mixture aims to reflect the global change in the average H3K79me2 level per cell. For our benchmarking, we selected two completely different conditions: i) the 25:75 (DMSO:EPZ5676)
proportion, which has higher levels of H3K79me2; and, ii) the 75:25 proportion, with lower 255 levels of H3K79me2 (Fig. 3 ). Finally, a constant amount of fly cells was used as an internal reference control for normalization.
We processed the H3K79me2 samples from the two different conditions. As indicated in our computational pipeline (Fig. 2) , first we mapped the resulting sequencing reads to an artificial genome in which we included the human and the fruit fly chromosomes. Next, we segmented 260 the genomes of the sample (human) and the spike-in control (fly) into bins of 1 Kb. After separating the mapped reads into human and fly, we assigned the average ChIP-seq value of H3K79me2 in both conditions within all bins from both genome segmentations (see Methods).
These initial values, which were not corrected by any normalization method, were considered to be the raw value (Fig. 2) . We then used the spike-in data to compute the normalization of 265 each bin using the fold-change (FC) methodology or our LOESS approach, respectively. For FC correction, we used the total number of aligned fly reads to correct the experimental human ChIP signal of both conditions, as previously suggested [21, 23] . For LOESS correction, we first normalized the spike-in sample for the total number of reads, and then applied the LOESS correction in the fly bins to the best fit-line ( Fig. 2 and 4) . Then, we used the same correction 270 factors, depending on the density of reads within the bins, to normalize the human experimental bins. An appropriately analytical normalization using spike-in should display a qualitative and quantitative difference between both experimental ChIP signals in the peaks of H3K79me2, while keeping their background levels equilibrated.
As shown in Figure 5a , either using the FC normalization or the LOESS approach, ChIP signal 275 strength is remarkably different between the 25:75 and the 75:25 samples. However, after a detailed inspection over the background regions, we consistently found a sustained increase also in such areas when using the FC correction. These genome-wide changes observed in the target occupancy over all background are misleading since the genomic distribution of H3K79me2 must be considered to be equivalent between both samples, as resulting from 280 mixing the same samples with different proportions. Instead, when using LOESS, the ChIP signal at background regions remains equilibrated (Fig. 5a ). In order to systematically determine the accuracy of both methods, we compared the average signal of all bins reported as peaks by MACS and the same value for rest of the bins of the human genome (background).
As anticipated, meta-plot and heatmap analysis centered on the bins corresponding to 285
H3K79me2 peaks displayed a disproportionate difference on the surrounding bins belonging to the background when using FC correction (Fig. 5b) . In contrast, the ChIP signal of background bins remains equilibrated between both conditions when using LOESS correction, as experimentally expected.
When quantifying the ChIP-seq signal in both classes of bins, the differences in the 290 background normalization resulted even more evident (Fig. 6 ). While applying the FC correction in human bins in a genome-wide manner, we quantified a general increase in ChIPsignal on the 25:75 sample with respect to the 75:25 sample in the background bins (19.7%, Fig. 6a ), which overall constitute more than 97% of total reads (Fig 6b) . In contrast, a near perfect balance was strikingly quantified on the bins that constitute the background level of the 295 ChIP-seq from the human experiments when using LOESS correction (+1.7%).
To our knowledge, the distinct gradual normalization from background to positive ChIP signal regions has not previously been considered in any of the existing normalization techniques.
We thus believe our proposal presents a major technical advance for the genome-wide normalization and for comparison of ChIP-seq experiments. 300
CONCLUSIONS
The ChIP technique is one of the most widely-used methods in molecular biology [26], since its development over 30 years ago [27] [28] [29] . The power of this technique has increased dramatically with the advent of the massive parallel sequencing approaches [8] [9] [10] [11] . Indeed, 305
ChIP-seq experiments have become the universal method to delineate the genome-wide maps of distribution of transcription factors, chromatin remodelers, and histone modifications. Since about a decade ago, the original scheme of ChIP-seq has been maintained substantially unmodified from chromatin isolation and fragmentation, immunoprecipitation using specific antibodies, DNA purification from protein complexes, library preparation, and parallel 310 sequencing. The ChIP-seq experiments endow a large proportion of noise, which can be introduced by the crosslinking artifacts, non-specific binding of the antibody, or the high sensitivity of the parallel sequencing techniques. This significant amount of noise results in many cases in most of the reads mapped into regions of the genome that are unrelated with the chromatin target (e.g. background zones). A precise determination of the signal-to-noise 315 ratio is, therefore, very relevant for determining the occupancy strength of the targets.
Limitations due to potential biases introduced by the technical variabilities in the original ChIPseq scheme have necessitated the development of strategies to implement an internal reference control across samples for further comparisons. However, there are still potential pitfalls in the application of each approach. Thus, this important problem is still open in many 320 aspects. Very recently, an additional spike-in strategy has been developed [30] . In this new approach, the authors benefit from the genetic diversity of yeast strains to perform an intraspecies spike-in using different Saccharomyces cerevisiae strains as spike-in and experimental specimen. Beyond its utility in lower eukaryotes, this new method exemplifies the aim to meet an experimental need. Considering the different strategies proposed to normalized 325
ChIP-seq data using spike-in, we provide here a major guideline to plan and perform comparative ChIP-seq experiments, and propose an innovative computational approach for the analysis in a genome-wide manner to fill the gap of the experimental need for an accurate interpretation of ChIP-seq data.
Our proposed standard for the genome-wide comparative ChIP-seq signal has shown to be 330 very effective for the precise comparison of ChIP signals across samples without a pre-defined selection of the loci. This approach is able to correct for possible technical bias and to compute a local correction factor, thereby minimizing the impact of the correction over non-occupied genomic regions. We strongly believe that the systematic use of spike-in references in the ChIP-seq experiments will provide a more precise picture of the dynamics of epigenome in 335 different conditions. The epigenetic research field is systematically searching to increase the sensitivity for minimizing the amount of cells required for analysis, with the aim of reaching a confident singlecell ChIP-seq. The high variability produced by manipulating single-cell events shall benefit from the introduction of internal reference controls, which are at the conceptual bottom line of 340 the methods reported here. We expect that single-cell Comp-ChIP-seq will bring this technique into a third revolution for tracking the genomic effects of molecules bound to single loci.
METHODS
Genome segmentation in bins of 1Kb 345
Using the UCSC genome browser, for each genome assembly of human and the fruit fly (hg19 and dm3, respectively), we retrieved the list of chromosomes and the corresponding sizes from the following sites: In total, after filtering the Het and M chromosome files out, we ended up with 3,095,665 bins for the human genome and 120,397 bins for the fruit fly genome.
365
Synthesis of the human+fruit fly genome
Firstly, we merged the full set of chromosomes of each genome assembly (hg19 for human and dm3 for Drosophila melanogaster) in FASTA format into a single file (genome.fa).Next, we appended the tag "_FLY" to the name of the fly chromosomes in the resulting FASTA file and in the chromInfo.txt file describe above to distinguish human from fly sequences. Finally, we used the command bowtie-build from the BOWTIE suite [31] to generate the corresponding indexes for posterior mapping of the ChIP-seq raw data files.
ChIP-seq raw data files and mapping 380
Using the NCBI GEO resource (GEO series accession: GSE60104), we retrieved the raw data of the samples Jurkat_K79_25%_R1 (GSM1465005) and Jurkat_K79_75%_R1 (GSM1465007) from [21] . Next, we utilized BOWTIE [31] to map both FASTQ files of reads over the human+fly genome indexes described above (BOWTIE parameters -p 4 -t -m 1 -S).
Finally, we used the SAMTOOLS [32] to filter the unaligned reads (option -F 0x4) out and, by 385 using the "_FLY" tag, the mapped reads corresponding to the fly spike-in control were then separated from the human experimental ones.
Canonical normalization of the ChIP-seq data values
For each experiment, we separately averaged the number of reads within each human and fly 390 bin using the SAMTOOLS [32] . Next, to assign the final value of one bin depending on the normalization method, we employed the following transformations ( 
Calculation of local regression normalization of the ChIP-seq data values
Generation of UCSC tracks, meta-plots and heatmaps
The resulting files of bins and values assigned according to each normalization strategy in both ChIP-seq conditions were directly used to generate BedGraph, meta-plots and heatmaps. In brief, the format of one of these input files was the following (human_bins_LOESS.txt): And the GAWK commands to generate the corresponding BedGraph profiles are: gawk 'BEGIN{FS="*"}{print $1,$2,$3}' human_bins_LOESS.txt | gawk 'BEGIN{OFS="\t"; print "track type=bedGraph name=FG_1Kb_loess_25_human visibility=full color=100,0,0"}{print 440 $1,$2,$3,$4}' > 1Kb_loess_25_human.bg; gawk 'BEGIN{FS="*"}{print $1,$2,$3}' human_bins_LOESS.txt | gawk 'BEGIN{OFS="\t"; print "track type=bedGraph name=FG_1Kb_loess_75_human visibility=full color=200,0,0"}{print $1,$2,$3,$5}' > 1Kb_loess_75_human.bg;
445
Discrimination of bins associated to peaks and to background MACS [33] was used to identify the list of ChIP-seq peaks along both genomes in the 25:75
and 75:25 conditions. To distinguish between bins that contain ChIP-seq peaks and bins that constitute the background, we calculated the overlap between MACS peaks and the coordinates of the segmentation bins at human and fly chromosomes. We used boxplots to 450 represent the distribution of normalized values that belongs to each class of bins.
LIST OF ABBREVIATIONS: 455
ChIP-seq: chromatin immunoprecipitation coupled with the next-generation sequencing RPM: reads per million LOESS: locally estimated scatterplot smoothing FC: Fold-change
460
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